197 related articles for article (PubMed ID: 32086712)
1. The Hitchhiker's Guide to Nucleocytoplasmic Trafficking in Neurodegeneration.
Moore S; Rabichow BE; Sattler R
Neurochem Res; 2020 Jun; 45(6):1306-1327. PubMed ID: 32086712
[TBL] [Abstract][Full Text] [Related]
2. Lost in Transportation: Nucleocytoplasmic Transport Defects in ALS and Other Neurodegenerative Diseases.
Kim HJ; Taylor JP
Neuron; 2017 Oct; 96(2):285-297. PubMed ID: 29024655
[TBL] [Abstract][Full Text] [Related]
3. Nuclear pore complex and nucleocytoplasmic transport disruption in neurodegeneration.
Cristi AC; Rapuri S; Coyne AN
FEBS Lett; 2023 Oct; 597(20):2546-2566. PubMed ID: 37657945
[TBL] [Abstract][Full Text] [Related]
4. Nucleocytoplasmic transport defects in neurodegeneration - Cause or consequence?
Hutten S; Dormann D
Semin Cell Dev Biol; 2020 Mar; 99():151-162. PubMed ID: 31152789
[TBL] [Abstract][Full Text] [Related]
5. RNA Nucleocytoplasmic Transport Defects in Neurodegenerative Diseases.
Boehringer A; Bowser R
Adv Neurobiol; 2018; 20():85-101. PubMed ID: 29916017
[TBL] [Abstract][Full Text] [Related]
6. The coming-of-age of nucleocytoplasmic transport in motor neuron disease and neurodegeneration.
Ferreira PA
Cell Mol Life Sci; 2019 Jun; 76(12):2247-2273. PubMed ID: 30742233
[TBL] [Abstract][Full Text] [Related]
7. Stress Granule Assembly Disrupts Nucleocytoplasmic Transport.
Zhang K; Daigle JG; Cunningham KM; Coyne AN; Ruan K; Grima JC; Bowen KE; Wadhwa H; Yang P; Rigo F; Taylor JP; Gitler AD; Rothstein JD; Lloyd TE
Cell; 2018 May; 173(4):958-971.e17. PubMed ID: 29628143
[TBL] [Abstract][Full Text] [Related]
8. Perturbations in Traffic: Aberrant Nucleocytoplasmic Transport at the Heart of Neurodegeneration.
Fahrenkrog B; Harel A
Cells; 2018 Nov; 7(12):. PubMed ID: 30486313
[TBL] [Abstract][Full Text] [Related]
9. Nucleocytoplasmic Transport: Regulatory Mechanisms and the Implications in Neurodegeneration.
Ding B; Sepehrimanesh M
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920577
[TBL] [Abstract][Full Text] [Related]
10. Nuclear pore dysfunction and disease: a complex opportunity.
Fare CM; Rothstein JD
Nucleus; 2024 Dec; 15(1):2314297. PubMed ID: 38383349
[TBL] [Abstract][Full Text] [Related]
11. Nuclear pore complexes - a doorway to neural injury in neurodegeneration.
Coyne AN; Rothstein JD
Nat Rev Neurol; 2022 Jun; 18(6):348-362. PubMed ID: 35488039
[TBL] [Abstract][Full Text] [Related]
12. Fifty years of nuclear pores and nucleocytoplasmic transport studies: multiple tools revealing complex rules.
Floch AG; Palancade B; Doye V
Methods Cell Biol; 2014; 122():1-40. PubMed ID: 24857723
[TBL] [Abstract][Full Text] [Related]
13. TDP-43 and FUS en route from the nucleus to the cytoplasm.
Ederle H; Dormann D
FEBS Lett; 2017 Jun; 591(11):1489-1507. PubMed ID: 28380257
[TBL] [Abstract][Full Text] [Related]
14. Inside out: the role of nucleocytoplasmic transport in ALS and FTLD.
Boeynaems S; Bogaert E; Van Damme P; Van Den Bosch L
Acta Neuropathol; 2016 Aug; 132(2):159-173. PubMed ID: 27271576
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA.
Woerner AC; Frottin F; Hornburg D; Feng LR; Meissner F; Patra M; Tatzelt J; Mann M; Winklhofer KF; Hartl FU; Hipp MS
Science; 2016 Jan; 351(6269):173-6. PubMed ID: 26634439
[TBL] [Abstract][Full Text] [Related]
16. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
Jovičić A; Paul JW; Gitler AD
J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
[TBL] [Abstract][Full Text] [Related]
17. Nuclear Envelope and Nuclear Pore Complexes in Neurodegenerative Diseases-New Perspectives for Therapeutic Interventions.
Hachiya N; Sochocka M; Brzecka A; Shimizu T; Gąsiorowski K; Szczechowiak K; Leszek J
Mol Neurobiol; 2021 Mar; 58(3):983-995. PubMed ID: 33067781
[TBL] [Abstract][Full Text] [Related]
18. Nuclear Pore Dysfunction in Neurodegeneration.
Spead O; Zaepfel BL; Rothstein JD
Neurotherapeutics; 2022 Jul; 19(4):1050-1060. PubMed ID: 36070178
[TBL] [Abstract][Full Text] [Related]
19. The karyopherin Msn5/Kap142 requires Nup82 for nuclear export and performs a function distinct from translocation in RPA protein import.
Belanger KD; Simmons LA; Roth JK; VanderPloeg KA; Lichten LB; Fahrenkrog B
J Biol Chem; 2004 Oct; 279(42):43530-9. PubMed ID: 15294903
[TBL] [Abstract][Full Text] [Related]
20. The FG-repeat asymmetry of the nuclear pore complex is dispensable for bulk nucleocytoplasmic transport in vivo.
Zeitler B; Weis K
J Cell Biol; 2004 Nov; 167(4):583-90. PubMed ID: 15557115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
